latest news releases from the newsroom
Vocus, Inc. Announces Exercise of Over-Allotment Option on Initial Public Offering
LANHAM, Md., Jan. 9, 2006 (PRIMEZONE) -- Vocus, Inc. (Nasdaq:VOCS) announced today that the underwriters of its initial public offering have exercised their over-allotment option in full to purchase from the selling stockholders identified in the offering prospectus an additional 750,000 shares of Vocus common stock at the initial public offering price of $9.00 per share.
Reeves Telecom Limited Partnership
Reeves Telecom Limited Partnership Responds to 'Mini-Tender' Offer for Its Limited Partnership Units
GLEN HEAD, N.Y., Jan. 9, 2006 (PRIMEZONE) -- On December 29, 2005, Reeves Telecom Limited Partnership received notification of an unsolicited mini-tender offer being made by Peachtree Partners, an Arizona-based partnership controlled by Messrs. Ira Gaines and Barry Zemel, to purchase up to 4.9% of the partnership units (including those partnership units Peachtree already owns) at a price of $0.10 cash per unit, less a one-time administrative fee of $100.00 per investor and less any distributions paid by the Partnership after December 12, 2005.
Care Choices Launches Online Customer Service
FARMINGTON HILLS, Mich., Jan. 9, 2006 (PRIMEZONE) -- Sometimes the best Customer Service is controlled by the customer. That's why Care Choices is launching the second phase of its Internet Self-Service (ISS), offering members the ability to go to the Web for secure access to their plan information 24 hours a day, seven days a week. The first phase, the physician portal, has been available since April, 2004.
Automated Meter Reading Industry Continues Steady Growth Amidst Bullish Predictions
ATLANTA, Jan. 9, 2006 (PRIMEZONE) -- Some experts predict advanced metering infrastructure (AMI) deployments are going to vastly increase over the next couple of years. However, current data shows AMI deployments and AMR vendors saw moderate gains in 2005 in sync with natural progression, according to one of Chartwell's latest Metering Research Series reports, AMR Vendors and Technologies 2006.
InRob Tech Ltd.
InRob Tech Ltd. Completes Military Trials of Remotely Controlled Hummer
LAS VEGAS, Jan. 9, 2006 (PRIMEZONE) -- InRob Tech Ltd. ("InRob") (OTCBB:IRBL), a leader in the development and production of advanced wireless control systems and integrated solutions for unmanned ground vehicles (UGV), today announced that it has successfully completed the development and field trials of a remote control system installed on a Hummer jeep. Any function that a driver can perform in the vehicle can now be remotely managed by an operator at distances of up to 1.8 miles. Moreover, in the same way that a driver can see the dashboard and in-vehicle dials and meters, the operator can see all these parameters on his control unit. This enables operators to manage the vehicle with or without eye contact, depending on field conditions.
Extreme Innovations, Inc.
Extreme Innovations, Inc. Signs Letter of Intent With T-Rex, Inc. for North American Distribution Rights
TAMPA, Fla., Jan. 9, 2006 (PRIMEZONE) -- Extreme Innovations, Inc. (Pink Sheets:EXTI) (www.extremeinnovationsinc.com) announced today it has signed a Letter of Intent with T-Rex, Inc. for the U.S. & Mexico Distribution Rights to America's fastest street legal performance vehicles on the market today, the T-Rex. The Letter of Intent gives Extreme Innovations, Inc. the rights to distribute the T-Rex through distribution centers and dealerships throughout North America.
TwinTrader.com Announces the Initiation of Profile Coverage for The BioBalance Corporation
DALLAS, Jan. 9, 2006 (PRIMEZONE) -- Reggie Sanchez, President of TwinTrader.com, announced Profile Coverage of The BioBalance Corp. (OTCBB:BBAL). Functioning as a specialty pharmaceutical company, The BioBalance Corp. is focused on the development of patented biotherapeutic agents for gastrointestinal disorders that are not adequately addressed by current therapies. These disorders include pouchitis, Irritable Bowel Syndrome (IBS), inflammatory bowel disease and diarrhea caused by antibiotics, chemotherapy or AIDS.